Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.47
BATS BZX Real-Time Price
As of 1:30pm ET
 -0.14 / -1.11%
Today’s Change
9.51
Today|||52-Week Range
17.53
-19.55%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.61
Today’s open12.71
Day’s range12.33 - 12.82
Volume570,466
Average volume (3 months)1,644,030
Market cap$1.7B
Dividend yield--
Data as of 1:15pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-27.55%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio61.7
Price/Sales9.80
Price/Book45.54

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...-0.13-1.65%
FGENFibroGen Inc+0.10+0.43%
DBVTDBV Technologies SA+0.77+1.77%
EXELExelixis Inc+0.28+4.89%
Data as of 1:30pm ET, 08/03/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts